{"url_path":"/sec/vani/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 [Unregistered Sales of Equity Securities and Use of Proceeds](#TOC)","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000852-index.html","accession_number":"0001753926-26-000852","cik":"0001266806","ticker":"VANI","issuer_name":"Vivani Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-000852-index.html","primary_entity_key":"0001266806","primary_entity_name":"Vivani Medical, Inc."},"word_count":80,"has_tables":true,"body_markdown":"Item 2. [Unregistered Sales of Equity Securities and Use of Proceeds](#TOC)\n\n \n\nOn January 25, 2026, we entered into a share purchase agreement with an entity affiliated with one of our independent directors for the purchase of an aggregate of 1,351,351 shares of our common stock at a purchase price of $1.48 per share, the last reported sale price of our common stock on January 23, 2026. This private placement of common stock resulted in gross proceeds of approximately $2.0 million."}